|
|
Article: First Results From University of Pittsburgh Medical Center Trial of Aerosol Cyclosporine Indicate Spray Improves Lung Function in Transplant Patients; Findings Presented at International Society for Heart and Lung Transplantation Meeting.
- Article from:
- PR Newswire
- Article date:
- April 10, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VIENNA -- VIENNA, April 10 /PRNewswire/ -- An aerosol form of the anti-rejection drug cyclosporine allows for improved lung function in lung transplant patients, according to researchers with the University of Pittsburgh Medical Center (UPMC) who presented their findings today at the 23rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT). Patients whose lungs were capable of depositing greater amounts of the drug had better lung function over the course of the two-year study than those who deposited less after inhalation or than patients who inhaled a spray with a placebo drug, the researchers reported.